Search for a trial

Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma, for evaluation of response in patients with progressive disease (Cohort 1) or as consolidative immunotherapy in patients in complete remission after relapse (Cohort 2)

Primary objectivesCohort 1 Estimate the efficacy of nivolumab treatment in patients with relapsed/refractory ALK+ ALCL in terms of best objective response rate within thefirst 24 weeksCohort 2 Estimate the efficacy of nivolumab treatment as…

Association of silicone breast implant Reconstruction and -Enlargement with Overall wellbeing, Lymphoma and Auto-immune disease - Anaplastic large cell lymphoma of the breast

1. To determine risk factors for BIA-ALCL in women with silicone breast implants. The associations between demographic-, reproductive- and lifestyle characteristics and BIA-ALCL risk among women with breast implants will be investigated. Furthermore…